Anti-Human CD70 Therapeutic Antibody (Vorsetuzumab Mafodotin)
Recombinant human monoclonal antibody expressed in CHO binding to human CD70. Vorsetuzumab mafodotin is an antibody-drug conjugate (ADC) directed to the protein CD70 designed for the treatment of cancer. It is a humanized monoclonal antibody, vorsetuzumab, conjugated with noncleavable monomethyl auristatin F (MMAF), a cytotoxic agent.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-882 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD70 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, ICC and most other immunological methods. |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |